Prior to founding Lontra Ventures in 2008, Walter Kalmans was Vice President, Business Development for Oncology Therapeutics Network (OTN), a subsidiary of McKesson Corporation. During his tenure at OTN, Walter was responsible for OTN's relationships with manufacturers and for delivering value-added services that helped manufacturers sell more product. Prior to joining OTN, Walter held senior commercial positions with Vignette, a software company, and Becton Dickinson & Company. Earlier in his career, he did healthcare consulting for several top firms, including Quintiles, Booz-Allen & Hamilton and Accenture. Walter earned a Bachelor of Science in Finance from the Wharton School and a Bachelor of Arts in Molecular Biology from the College of Arts & Sciences, both at the University of Pennsylvania. He holds a Masters in Business Administration from the Fuqua School of Business at Duke University where he graduated as a JB Fuqua Scholar.